Journal profile · CELL & TISSUE ENGINEERING
Journal of Stem Cells & Regenerative Medicine
ISSN 0973-7154 · GN Corporation Limited · Japan
Journal of Stem Cells & Regenerative Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 380; review about 14 weeks (community reports); 15 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Stem Cells & Regenerative Medicine is published by GN Corporation Limited and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Mesenchymal stem cell research, Pluripotent Stem Cells Research and Tissue Engineering and Regenerative Medicine, together about 44.3% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Stem cells and Regenerative Medicine (JSRM), an official journal of the German Society for Stem Cell Research (GSZ) is an Open access Online Journal covering areas of Basic Research, Translational work and Clinical studies in the specialty of Stem Cells and Regenerative Medicine including allied specialities such as Biomaterials and Nano technology relevant to the core subject.
From the journal's Aims & Scope
Research area (LetPub): CELL & TISSUE ENGINEERING
Editorial board by country: none in mainland China; most named United States 1, Japan 1, India 1, Germany 1, New Zealand 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Mesenchymal stem cell researchMedicine19.5%
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology13%
- Tissue Engineering and Regenerative MedicineMedicine11.9%
- Biomedical Ethics and RegulationMedicine7.9%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science4.5%
- Periodontal Regeneration and TreatmentsMedicine4.5%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology4%
- 3D Printing in Biomedical ResearchEngineering3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell & Tissue Engineering | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell & Tissue Engineering | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.4LetPub ·
- SJR 2026-06
- 0.33LetPub ·
- SNIP 2026-06
- 0.32LetPub ·
- h-index
- 24OpenAlex ·
- i10-index
- 63OpenAlex ·
- 2-year mean citedness
- 0.7OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 86.67%LetPub ·
Volume
- Articles per year
- 8LetPub ·
Articles by year OpenAlex count · 267 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 7 | 7 | 0 |
| 2025 | 15 | 15 | 4 |
| 2024 | 11 | 11 | 19 |
| 2023 | 10 | 10 | 7 |
| 2022 | 14 | 14 | 45 |
| 2021 | 13 | 13 | 80 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 9 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 380 | No | CC BY | |
| OpenAlex | USD 380 | — | — | |
| LetPub | USD 380 | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- ≤ 5
- Manuscript length
- ≤ 4,000 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
Article types accepted8, with length limits
- book reviewsvi. Others (JSRM CODE: 08): Book Reviews: Reviews on published books in the field of Stem cells, Regenerative medicine and other allied fields are welcome but p…Length not stated
- brief communication/case reportiii. Brief Communication/Case report (JSRM CODE: 04): Brief communications can involve short analytical reports; experimental procedures and observations of hig…Length not stated
- letters to the editoriv. Letters to the editor (JSRM CODE: 06): Letters to the editor in general express the feedback or asking for clarification or comment on earlier published art…Length not stated
- opinionn in the form of a more general review. Opinions should be brief and the length should not exceed 1000 words and references upto 25 are allowed. Publication of …main text ≤ 1,000 words
- opinionsOpinions: These are articles discussing on topics on personal/opinion based standpoint rather than in the form of a more general review.Length not stated
- original articlei. Original Article (JSRM CODE: 03): Original research articles should be novel and present a work of substantial significance to the readers.Length not stated
- proceedings of a meetingv. Proceedings of a meeting (JSRM CODE: 07): JSRM welcomes proceedings of meetings.Length not stated
- review articleii. Review Article (JSRM CODE: 02): JSRM welcomes Reviews that focus on recent clinical and research advances in the allied topics of interest to the readers.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, License & copyright
- Authorship Authorship:
Authorship should be credited based on all of the four following criteria:
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest:
It is mandatory for each author to disclose all relevant potential financial and other interests that might be influencing the results and contents of the manuscript. On submission, the corresponding author will be sent the Conflict of Interest Declaration form by email and It is the duty of the corresponding author to ensure that that all the authors of the manuscript sign the Conflict of interes…
Source ↗Publisher website ·- License & copyright Copyright
Creative Commons Attribution 3.0 Unported License Model summary
Upon submission of any article, the corresponding author will be sent a Copyright transfer form by email. It is the duty of the corresponding author to ensure that that all the authors of the manuscript sign the Copyright transfer form and the scanned copy of the duly signed form must be returned to JSRM by email. Only on receipt of the Copyright transfer form will the manuscript be eligible for p…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- GN Corporation Limited
- Country or region
- Japan
- Language
- English
- ISSN
- 0973-7154
- Society / sponsor
- German Society for Stem Cell Research
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Journal of Stem Cells & Regenerative Medicine
What CAS zone is Journal of Stem Cells & Regenerative Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Stem Cells & Regenerative Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Cell & Tissue Engineering. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Journal of Stem Cells & Regenerative Medicine?
Authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Stem Cells & Regenerative Medicine?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: ≤ 5; Manuscript length: ≤ 4,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Stem Cells & Regenerative Medicine based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (1), Japan (1) and India (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Stem Cells & Regenerative Medicine?
According to LetPub and DOAJ records, Journal of Stem Cells & Regenerative Medicine is indexed in ESCI, Scopus and DOAJ.
Is Journal of Stem Cells & Regenerative Medicine open access, and what is the APC?
Journal of Stem Cells & Regenerative Medicine is a fully open-access journal. APC about USD 380.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .